RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/18768470http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18768470http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18768470http://www.w3.org/2000/01/rdf-schema#comment"Transforming growth factor beta family ligands are neutralized by a number of structurally divergent antagonists. Follistatin-type antagonists, which include splice variants of follistatin (FS288 and FS315) and follistatin-like 3 (FSTL3), have high affinity for activin A but differ in their affinity for other ligands, particularly bone morphogenetic proteins. To understand the structural basis for ligand specificity within FS-type antagonists, we determined the x-ray structure of activin A in complex with FSTL3 to a resolution of 2.5 A. Similar to the previously resolved FS.activin A structures, the ligand is encircled by two antagonist molecules blocking all ligand receptor-binding sites. Recently, the significance of the FS N-terminal domain interaction at the ligand type I receptor site has been questioned; however, our data show that for FSTL3, the N-terminal domain forms a more intimate contact with activin A, implying that this interaction is stronger than that for FS. Furthermore, binding studies revealed that replacing the FSTL3 N-terminal domain with the corresponding FS domain considerably lowers activin A affinity. Therefore, both structural and biochemical evidence support a significant interaction of the N-terminal domain of FSTL3 with activin A. In addition, structural comparisons with bone morphogenetic proteins suggest that the interface where the N-terminal domain binds may be the key site for determining FS-type antagonist specificity."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.org/dc/terms/identifier"doi:10.1074/jbc.m801266200"xsd:string
http://purl.uniprot.org/citations/18768470http://purl.org/dc/terms/identifier"doi:10.1074/jbc.m801266200"xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Sidis Y."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Sidis Y."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Thompson T.B."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Thompson T.B."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Keutmann H.T."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Keutmann H.T."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Kattamuri C."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Kattamuri C."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Schneyer A."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Schneyer A."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Stamler R."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/author"Stamler R."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/name"J. Biol. Chem."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/name"J. Biol. Chem."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/pages"32831-32838"xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/pages"32831-32838"xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/title"The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity."xsd:string
http://purl.uniprot.org/citations/18768470http://purl.uniprot.org/core/title"The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity."xsd:string